Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-2 of 2
Keywords: SGLT2
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Determining the role of SGLT2 inhibition with Empagliflozin in the development of diabetic retinopathy
Open AccessJennifer Matthews, Lakshini Herat, Jennifer Rooney, Elizabeth Rakoczy, Markus Schlaich, Vance B. Matthews
Journal:
Bioscience Reports
Biosci Rep (2022) 42 (3): BSR20212209.
Published: 02 March 2022
... devastating complications for patients is diabetic retinopathy (DR) which represents the leading cause of preventable vision loss in people between 20 and 65 years of age. Sodium glucose transporter 2 (SGLT2) inhibitors have been shown to reduce the risk for cardiovascular and renal events, however literature...
Includes: Supplementary data
Articles
Heinz Drexel, Andreas Leiherer, Christoph H. Saely, Eva Maria Brandtner, Kathrin Geiger, Alexander Vonbank, Peter Fraunberger, Axel Muendlein
Journal:
Bioscience Reports
Biosci Rep (2019) 39 (8): BSR20190299.
Published: 07 August 2019
...Heinz Drexel; Andreas Leiherer; Christoph H. Saely; Eva Maria Brandtner; Kathrin Geiger; Alexander Vonbank; Peter Fraunberger; Axel Muendlein Inhibition of the sodium glucose co-transporter 2 (SGLT2) reduces cardiovascular morbidity, and mortality in patients with type 2 diabetes mellitus (T2DM...
Includes: Supplementary data